Table 1 Percentage distribution of clinical features in post-COVID mucormycosis cases
From: Management of post-COVID mucormycosis at a tertiary care center in Northern India
S no. | Clinical feature | Percentage of patients |
|---|---|---|
1. | Nasal obstruction | 80% |
2. | Orbital swelling | 70% |
3. | Headache | 65% |
4. | Visual loss/diplopia | 45% |
5. | Fever | 35% |
6. | Epistaxis | 30% |
7. | Nasal discharge | 50% |
8. | Disorientation | 45% |